Lothar Kanz
Active 1987–2022
- 149
- Papers
- 28,116
- Citations
- 107
- h-index
- 149
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine67.5%
- Immunology and Microbiology17.7%
- Biochemistry, Genetics and Molecular Biology12.3%
- Neuroscience1%
- Engineering0.4%
- Materials Science0.3%
- Other0.8%
Topics
- Immunotherapy and Immune Responses4.6%
- Immune Cell Function and Interaction4.6%
- CAR-T cell therapy research3.9%
- Lymphoma Diagnosis and Treatment3.8%
- Acute Myeloid Leukemia Research3.7%
- Hematopoietic Stem Cell Transplantation3.3%
- Other76.1%
Coauthors
- Carsten Bokemeyer25
- Wolfram Brugger24
- Peter Brossart15
- Christian Kollmannsberger14
- Hermann Einsele14
- J.T. Hartmann13
- Hans‐Jörg Bühring12
- A. Gerl11
- Hans‐Joachim Schmoll11
- J. Beyer11
- Hans‐Georg Rammensee10
- Michael Lauseker10
- Michael Pfreundschuh10
- Robert Möhle10
- Alice Fabarius9
- Arnold Ganser9
- Christiane Falge9
- Frank Grünebach9
- Markus Pfirrmann9
- Ulrike Proetel9
- Andreas Neubauer8
- Bernd Metzner8
- Brigitte Schlegelberger8
- Frank Stegelmann8
All papers
- Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Authors: Anna Paczulla, Kathrin Rothfelder, Simon Raffel, Martina Konantz, Julia Steinbacher, Hui Wang, Claudia Tandler, Marcelle Ndoh Mbarga, Thorsten Schaefer, Mattia Falcone, Eva Nievergall, Daniela Dörfel, Pauline Hanns, Jakob Passweg, Christoph Lutz, Juerg Schwaller, Robert Zeiser, Bruce R. Blazar, Michael A. Caligiuri, Stephan Dirnhofer, Pontus Lundberg, Lothar Kanz, Leticia Quintanilla‐Martínez, Alexander Steinle, Andreas Trumpp, Helmut R. Salih, Claudia Lengerke - Nature 2019 cited by 393
- Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study
Authors: Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot, Peter Kufer, Max S. Topp, Hermann Einsele, Richard Noppeney, Georg Heß, С. Каллерт, Andréas Mackensen, Kathrin Rupertus, Lothar Kanz, M. Libicher, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Andreas Wolf, B Dorsch, Beate D. Quednau, Margit Schmidt, J. Scheele, Patrick A. Baeuerle, Eugen Leo, Ralf C. Bargou - Journal of Clinical Oncology 2016 cited by 421
- Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Authors: for the SAKK and the German CML Study Group, Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele, Markus Pfirrmann, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, C. Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Dominik Heim, Tim H. Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Marcus Müller, Sabine Jeromin, Ulrike Proetel, Katharina Kohlbrenner, Astghik Voskanyan, Sébastien Rinaldetti, Wolfgang Seifarth, Birgit Spieß, Leopold Balleisen, M-E Goebeler, Mathias Hänel, Anthony D. Ho, Jolanta Dengler, Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 cited by 339
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Authors: Eckhard Thiel, Agnieszka Korfel, Peter Martus, Lothar Kanz, Frank Griesinger, Michael Rauch, Alexander Röth, Bernd Hertenstein, Theda von Toll, Thomas Hundsberger, H.‐G. Mergenthaler, Malte Leithäuser, Tobias Birnbaum, Lars Fischer, Kristoph Jahnke, Ulrich Herrlinger, Ludwig Plaßwilm, Thomas Nägele, Torsten Pietsch, Michael Bamberg, Michael Weller - The Lancet Oncology 2010 cited by 622
- Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
Authors: Jörg Henes, Maria Carolina Oliveira, Myriam Labopin, Manuela Badoglio, Hans Ulrich Scherer, Nicoletta Del Papa, Thomas Daikeler, Marc Schmalzing, Roland Schroers, Thierry Martin, G. Pugnet, Belinda Pinto Simões, David Michonneau, Erik W.A. Marijt, Bruno Lioure, Jacques Olivier Bay, John A. Snowden, Montserrat Rovira, Anne Huynh, Francesco Onida, Lothar Kanz, Zora Marjanovic, Dominique Farge - Haematologica 2020 cited by 121
- Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Authors: Helmut R. Salih, Holger Antropius, Friederike Gieseke, Stefan Lutz, Lothar Kanz, Hans‐Georg Rammensee, Alexander Steinle - Blood 2003 cited by 532
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
Authors: Susanne M. Rittig, Maik Haentschel, Katrin J Weimer, Annkristin Heine, Martin Müller, Wolfram Brugger, Marius Horger, Olga Maksimovic, Arnulf Stenzl, Ingmar Hoerr, Hans‐Georg Rammensee, Tobias A.W. Holderried, Lothar Kanz, Steve Pascolo, Peter Brossart - Molecular Therapy 2010 cited by 219
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network
Authors: Eva Hoster, Andreas Rosenwald, Françoise Berger, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Stephan Stilgenbauer, Roswitha Forstpointner, Catherine Thiéblemont, Michael Hallek, Bertrand Coiffier, Ursula Vehling‐Kaiser, Réda Bouabdallah, Lothar Kanz, Michael Pfreundschuh, Christian Schmidt, Vincent Ribrag, Wolfgang Hiddemann, Michael Unterhalt, Johanna C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfgang Hiddemann - Journal of Clinical Oncology 2016 cited by 362
- Human Signal-Regulatory Protein Is Expressed on Normal, But Not on Subsets of Leukemic Myeloid Cells and Mediates Cellular Adhesion Involving Its Counterreceptor CD47
Authors: Martina Seiffert, Charles Cant, Zhengjun Chen, Irène Rappold, Wolfram Brugger, Lothar Kanz, Eric J. Brown, Axel Ullrich, Hans‐Jörg Bühring - Blood 1999 cited by 294
- Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
Authors: Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Christian H. Geisler, Marek Trněný, Stephan Stilgenbauer, Florian Kaiser, Jeanette K. Doorduijn, Gilles Salles, Michał Szymczyk, Hervé Tilly, Lothar Kanz, Christian Schmidt, Pierre Feugier, Catherine Thiéblemont, Josée M. Zijlstra, Vincent Ribrag, Wolfgang Hiddemann, Christiane Pott, Michael Unterhalt, Martin Dreyling - Journal of Clinical Oncology 2019 cited by 143
- High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Authors: Olivier Hermine, Linmiao Jiang, Jan Walewski, André Bosly, Catherine Thiéblemont, Michał Szymczyk, Christiane Pott, Gilles Salles, Pierre Feugier, Kai Hübel, Corinne Haïoun, Olivier Casasnovas, Christian Schmidt, Kamal Bouabdallah, Vincent Ribrag, Lothar Kanz, Jan Dürig, Bernd Metzner, David Sibon, Morgane Cheminant, Barbara Burroni, Wolfgang Hiddemann, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Martin Dreyling, on behalf of the European Mantle Cell Lymphoma Network - Journal of Clinical Oncology 2022 cited by 56
- Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience
Authors: Christian Kollmannsberger, K. Mross, A. Jakob, Lothar Kanz, Carsten Bokemeyer - Oncology 1999 cited by 215
- The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1
Authors: Robert Möhle, Frank Bautz, Shahin Rafii, Malcolm A.S. Moore, Wolfram Brugger, Lothar Kanz - Blood 1998 cited by 635
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Authors: Andreas Engert, Heinz Haverkamp, Carsten Kobe, Jana Marková, Christoph Renner, Antony D. Ho, Josée M. Zijlstra, Zdeněk Král, Michael Fuchs, Michael Hallek, Lothar Kanz, Hartmut Döhner, Bernd Dörken, Nicole Engel, Max S. Topp, Susanne Klutmann, Holger Amthauer, Andreas Bockisch, Regine Kluge, Clemens Kratochwil, Otmar Schober, Richard Greil, Reinhard Andreesen, Michael Kneba, Michael Pfreundschuh, Harald Stein, Hans Theodor Eich, Rolf‐Peter Müller, Markus Dietlein, Peter Borchmann, Volker Diehl - The Lancet 2012 cited by 632
- Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
Authors: Christoph Schmid, Liesbeth C. de Wreede, Anja van Biezen, Jürgen Finke, Gerhard Ehninger, Arnold Ganser, Liisa Volin, Dietger Niederwieser, Dietrich W. Beelen, P Alessandrino, Lothar Kanz, Michael Schleuning, Jakob Passweg, Hendrik Veelken, Johan Maertens, Jan J. Cornelissen, Didier Blaise, Martin Gramatzki, Nöel Milpied, Ibrahim Yakoub‐Agha, Ghulam Mufti, Montserrat Rovira, Renate Arnold, Théo de Witte, Marie Robin, Nicolaus Kröger - Haematologica 2017 cited by 128
- Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Authors: Donal P. McLornan, Richard Szydlo, Linda Köster, Yves Chalandon, Marie Robin, Christine Wolschke, Dietrich W. Beelen, Gerard Socié, Martin Bornhäuser, Emanuele Angelucci, Dietger Niederwieser, Arnim Gerbitz, Jürgen Finke, Antonı́n Vı́tek, Maija Itälä‐Remes, Aleksandar Radujkovic, Lothar Kanz, Victoria Potter, Patrice Chevallier, Matthias Stelljes, Eefke Petersen, Stephen Robinson, Xavier Poiré, Evgeny Klyuchnikov, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Patrick Hayden, Nicolaus Kröger, Ibrahim Yakoub‐Agha - Biology of Blood and Marrow Transplantation 2019 cited by 98
- Novel Markers for the Prospective Isolation of Human MSC
Authors: Hans‐Jörg Bühring, Venkata Lokesh Battula, Sabrina Treml, B. Schewe, Lothar Kanz, Wichard Vogel - Annals of the New York Academy of Sciences 2007 cited by 453
- Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
Authors: Lida Kalmanti, Susanne Saußele, Michael Lauseker, M. C. Muller, Christian Dietz, Linda Heinrich, Benjamin Hanfstein, Ulrike Proetel, Alice Fabarius, Stefan W. Krause, Sébastien Rinaldetti, Jolanta Dengler, Christiane Falge, Elisabeth Oppliger Leibundgut, Andreas Burchert, Andreas Neubauer, Lothar Kanz, Frank Stegelmann, Michael Pfreundschuh, Karsten Spiekermann, Christof Scheid, Markus Pfirrmann, Andreas Hochhaus, Joerg Hasford, R. Hehlmann, for the SAKK and the German CML Study-Group - Leukemia 2015 cited by 274
- Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
Authors: Lena Axt, Aline Naumann, J. Toennies, Sebastian P. Haen, Wichard Vogel, Dominik Schneidawind, Stefan Wirths, R. Moehle, C. Faul, Lothar Kanz, Steffen Axt, Wolfgang Bethge - Bone Marrow Transplantation 2019 cited by 109
- Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
Authors: Hermann Einsele, Eddy Roosnek, Nathalie Rufer, Christian Sinzger, Susanne Riegler, Jürgen Löffler, Ulrich Grigoleit, Arnaud Moris, Hans‐Georg Rammensee, Lothar Kanz, Annette Kleihauer, Friederike Frank, Gerhard Jahn, Holger Hebart - Blood 2002 cited by 701
- Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
Authors: Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Catherine Thiéblemont, Michał Szymczyk, Réda Bouabdallah, Michael Kneba, Michael Hallek, Gilles Salles, Pierre Feugier, Vincent Ribrag, Josef Birkmann, Roswitha Forstpointner, Corinne Haïoun, Mathias Hänel, Olivier Casasnovas, Jürgen Finke, Norma Peter, Kamal Bouabdallah, Catherine Sebban, Thomas Fischer, Ulrich Dührsen, Bernd Metzner, Georg Maschmeyer, Lothar Kanz, Christian Schmidt, Richard Delarue, Nicole Brousse, Wolfgang Hiddemann, Elizabeth Macintyre, Marie‐Hélène Delfau‐Larue, Christiane Pott, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling - The Lancet 2016 cited by 401
- Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV
Authors: Alice Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Müller, Benjamin Hanfstein, Claudia Haferlach, Gudrun Göhring, Brigitte Schlegelberger, Martine Jotterand, Andreas Reiter, Susanne Jung-Munkwitz, Ulrike Proetel, Juliana Schwaab, Wolf‐Karsten Hofmann, Jörg Schubert, Hermann Einsele, Anthony D. Ho, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Michael Lauseker, Markus Pfirrmann, Joerg Hasford, Susanne Saußele, Rüdiger Hehlmann, for the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group - Blood 2011 cited by 290
- SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
Authors: Petra M. Bareiss, Anna Paczulla, Hui Wang, Rebekka Schairer, Stefan Wiehr, Ursula Kohlhofer, Oliver C. Rothfuss, Anna Fischer, Sven Perner, Annette Staebler, D. Wallwiener, Falko Fend, Tanja Fehm, Bernd J. Pichler, Lothar Kanz, Leticia Quintanilla‐Martínez, Klaus Schulze‐Osthoff, Frank Eßmann, Claudia Lengerke - Cancer Research 2013 cited by 152
- Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
Authors: B. Hanfstein, Michael Lauseker, R Hehlmann, Susanne Saußele, Philipp Erben, Christian Dietz, Alice Fabarius, Ulrike Proetel, Susanne Schnittger, Claudia Haferlach, Stefan W. Krause, Jörg Schubert, Hermann Einsele, Mathias Hänel, Jolanta Dengler, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, M Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Markus Pfirrmann, Joerg Hasford, W.‐K. Hofmann, Andreas Hochhaus, Martin Müller, for the SAKK and the German CML Study Group - Haematologica 2014 cited by 119
